Medicis Loprox Rx shampoo
This article was originally published in Pharmaceutical Approvals Monthly
Executive Summary
FDA approves the first prescription antifungal shampoo Feb. 28, Medicis' Loprox (ciclopirox 1%) for the treatment of seborrheic dermatitis of the scalp in adults. The firm estimates approximately eight million Americans are affected by the chronic skin condition. The most common side effects of the shampoo are rash or other discomfort around the scalp. Loprox is already available in gel and lotion formulation
You may also be interested in...
Probiotics And Cold Remedies Boost Recordati In 2023
Italy's Recordati saw its OTC sales grow by 10% in 2023 driven by the recovery of the cough & cold market and a growing demand for probiotics.
Falling Sales Force New Priorities At Roche
The Swiss major brings a new ruthlessness to the compounds in its pipeline: if they’re not first or best, they’re out.
Human Cell-Secreted Proteins Offer A Wellspring Of Potential Therapeutics
CEO Hanadie Yousef leads Juvena Therapeutics in utilizing an AI-based platform that analyzes cell-secreted proteins to identify potential therapeutics. One of their first near-clinical assets could complement GLP-1s.